64Cu-DOTHA2-PSMA

N/A

Report date: 2025/10/31 15:08:04

NME

Base Information

Drug Name64Cu-DOTHA2-PSMA

Drug Alias NameCopper-64-DOTHA2-PSMA

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionProstate-specific antigen modulators

TargetsProstate-specific antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Sherbrooke

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Sherbrooke

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A